ArticleChemMedChem2026

Discovery of [1,2,4]triazolo[1,5-a]pyrimidine-Imatinib Hybrids With Selective Cytotoxic Activity: A Mechanistically Divergent Series From Direct BCR-ABL1 Inhibition.

Stefany Castro Bazan Moura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.